{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:48:03Z","timestamp":1764402483334},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.094","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T09:30:10Z","timestamp":1294392610000},"page":"1551-1557","source":"Crossref","is-referenced-by-count":19,"title":["Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP\u2013IPV) compared to separate administration of standalone DTaP and IPV vaccines: A randomized, controlled study in infants in the Republic of Korea"],"prefix":"10.1016","volume":"29","author":[{"given":"Soo Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Sung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Hee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hyuk","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Keun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Guitton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Han","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl B","key":"10.1016\/j.vaccine.2010.12.094_bib0005","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.18553\/jmcp.2007.13.s7-b.12","article-title":"Economic benefits and costs associated with target vaccinations","volume":"7","author":"Armstrong","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0015","series-title":"Vaccines","first-page":"467","article-title":"Pertussis vaccines","author":"Edwards","year":"2008"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.bmb.a011700","article-title":"Advances and challenges for the expanded programme on immunization","volume":"54","author":"Cutts","year":"1998","journal-title":"Br Med Bull"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2010.12.094_bib0025","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/nm1209","article-title":"Vaccines: past, present and future","volume":"11","author":"Plotkin","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.13.2.302-317.2000","article-title":"Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates","volume":"13","author":"Peltola","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"11Suppl","key":"10.1016\/j.vaccine.2010.12.094_bib0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/00006454-200111001-00002","article-title":"Principles of pediatric combination vaccines and practical issues related to use in clinical practice","volume":"20","author":"Decker","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","article-title":"The use of combination vaccines has improved timeliness of vaccination in children","volume":"25","author":"Kalies","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2010.12.094_bib0045","first-page":"S6","article-title":"Benefits of combination vaccines: effective vaccination on a simplified schedule","volume":"9","author":"Dodd","year":"2003","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0050","unstructured":"WHO Vaccine Preventable Diseases Monitoring System 2009 Global Summary; Cited Jan 2010. Available from: http:\/\/www.who.int\/vaccines\/globalsummary\/immunization\/countryprofileselect.cfm [accessed 24.01.10]."},{"key":"10.1016\/j.vaccine.2010.12.094_bib0055","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.vaccine.2008.10.075","article-title":"The comparative evaluation of expanded national immunization policies in Korea using an analytic hierarchy process","volume":"27","author":"Shin","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/BF01690510","article-title":"Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria\u2013tetanus\u2013pertussis vaccines in Senegalese infants","volume":"15","author":"Simondon","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0065","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0264-410X(97)00100-X","article-title":"Randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal","volume":"15","author":"Simondon","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00006454-199703000-00011","article-title":"Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine","volume":"16","author":"Vidor","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00006454-199804000-00006","volume":"17","author":"Lagos","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0080","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00006454-199811000-00013","article-title":"Safety and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, inactivated polio vaccine Haemophilus influenzae type b vaccine administered at 2\u20134\u20136\u201313 or 3\u20135\u201312 months of age","volume":"17","author":"Carlsson","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0085","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/00006454-200012000-00001","article-title":"Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants","volume":"19","author":"Mallet","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0090","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0264-410X(99)00331-X","volume":"18","author":"Kanra","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0095","first-page":"443","article-title":"Immunogenicity and safety of a DTaP\u2013IPV\/\/PRP-T combination vaccine at 6, 10, 14 weeks of age (EPI schedule) and concomitant Hepatitis B vaccination at birth, 6, 14 or 6, 10, 14 weeks of age","volume":"86","author":"Capeding","year":"2008","journal-title":"WHO Bull"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0100","first-page":"975","article-title":"Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate combination vaccine (Pentaxim\u2122) at 6, 10, 14 weeks of age","volume":"46","author":"Dutta","year":"2009","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0105","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/00006454-200206000-00011","article-title":"Antibody persistence in five-year old children who received a pentavalent combination vaccine in infancy","volume":"21","author":"Carlsson","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4161\/hv.4.5.6008","article-title":"Immunogenicity of a two-component (PT & FHA) acellular pertussis vaccine in various combinations","volume":"4","author":"Vidor","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00006454-200101000-00013","article-title":"Immunologic correlates of protection induced by vaccination","volume":"20","author":"Plotkin","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0120","series-title":"The 14th European Societies for Paediatric Infectious Diseases","article-title":"Primary immunization with combined, acellular DTaP\u2013IPV\u2013Act\u2013HIB vaccine given at 2\u20133\u20134 or 2\u20134\u20136 months of age","author":"Mallet","year":"1996"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0125","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3345\/kjp.2006.49.8.864","article-title":"Immunogenicity and safety of enhanced-inactivated poliovaccine (eIPV) in healthy Korean infants","volume":"49","author":"Kim","year":"2006","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0130","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1542\/peds.2005-2746","article-title":"Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age","volume":"8","author":"Gustafsson","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0135","unstructured":"Swedish Institute for Infectious Disease Control. Pertussis surveillance in Sweden with enhanced follow-up of cohorts immunized with acellular pertussis vaccines 2006 Appendix 2 SP-MSD. Available from: http:\/\/www.smittskyddsinstitutet.se\/upload\/Publikationer\/11-y-report-app202-SPMSD.pdf [accessed 12.03.10]."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2010.12.094_bib0140","first-page":"S75","article-title":"Effectiveness of the 2-component acellular pertussis combination vaccine 5 years experience of routine practice in Sweden","volume":"8","author":"Hessel","year":"2004","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2807\/esm.04.12.00084-en","article-title":"Marked decline in pertussis followed reintroduction of pertussis vaccination in Sweden","volume":"4","author":"Olin","year":"1999","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0150","unstructured":"Nilsson L, Rydevik G. Eleven Year Report: Pertussis surveillance in Sweden Progress Report October 1, 1997\u2013December 31, 2008 with an executive summary. Available from: http:\/\/www.smittskyddsinstitutet.se\/upload\/Publikationer\/smirapport-06-2009.pdf [accessed 12.03.10]."},{"key":"10.1016\/j.vaccine.2010.12.094_bib0155","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1542\/peds.81.6.933","article-title":"Report of the task force on pertussis and pertussis immunization\u20141988","volume":"81","author":"Cherry","year":"1988","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.96.3.557","article-title":"Comparison of 13 acellular pertussis vaccines: adverse reactions","volume":"96","author":"Decker","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.12.094_bib0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T19:38:08Z","timestamp":1685907488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10018785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10018785"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.094","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}